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In about 1–2% of the population an incomplete regression of the embryonic mammary line
occurs, which may result in the presence of ectopic breast tissue. An ectopic breast tis-
sue  carcinoma is a rare entity. The authors present a case-report of a 51-year-old female
patient, with a lobular carcinoma in an axillary ectopic breast tissue submitted to surgery
and  adjuvant radiotherapy.eywords:
reast cancer
arcinoma lobular
ctopic breast tissue
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physician referring no improvement of the inﬂammatory.  Background
n about 1–2% of the population an incomplete regression of
he embryonic milk line occurs that extends from the axilla
o the external genitalia, which may lead to the presence of
ctopic breast tissue (EBT). Less commonly, accessory breasts
ppear in locations outside the milk line, such as the face,
osterior neck, chest, middle back, vulva, ﬂank, hip, posterior
nd/or lateral thigh, shoulder, and upper extremities.1–6
In 1915, Kajava published a classiﬁcation system for super-
umerary breast tissue that remains in use today. It divides
n ectopic breast tissue into different groups according to the
resence of different components, such as the areola, the nip-
le or glandular tissue.2,5,7
The presence of an ectopic breast tissue is a rare diagnosis,
ccurring in 0.2–6% of the population. The axilla is the most
requent location representing 60–70% of all cases, followed
y the vulva and chest region. Nevertheless, accessory small
ipples are commonly seen especially below the breasts.1,4,6–11
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ttp://dx.doi.org/10.1016/j.rpor.2013.03.003Ectopic breast tissue carcinomas are very rare, accounting
for 0.2–0.6% of all breast cancers.1,2,6–8 Ductal carcinoma is the
most common histology with 45–80% of all cases followed by
lobular carcinoma that represents less than 10%.1,2,6–8
The authors intend to present a case report of a rare diagno-
sis, warn about this entity and show the importance of prompt
diagnosis and proper treatment.
2.  Case  report
The patient is a 51-year-old post-menopausal white female
with no family history of cancer. She reported to her attending
physician due to the appearance of inﬂammatory signals in
the left axillary mass diagnosed as lipoma 20 years ago.
After 1 week of antibiotics, the patient returned to the. Soares).
signs.
Afterwards, she was submitted to surgical excision of the
left axillary mass. The pathology revealed a 2.5 cm invasive
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lobular carcinoma with involvement of the dermis (without
ulceration of the skin). The immunohistochemical studies
revealed positivity for estrogen and progesterone hormonal
receptors (>95%) and HER2 negative.
After the diagnosis of cancer, the patient underwent
image studies with mammography, breast ultrasonography
and bilateral MRI  that revealed two nodular formations in the
left breast. The ﬁne needle biopsy performed in both lesions
showed no signs of malignancy.
Once admitted in our institution and evaluated by a multi-
disciplinary tumor board, the patient underwent an extended
excision of the surgical scar and left axillary node dissection.
The histological study revealed residual lobular carcinoma
with 0.8 cm in diameter and foci of lobular in situ carcinoma.
In the axillary node dissection, 9 lymph nodes were isolated
without metastasis. The surgical margins were free. The lesion
was staged as a pT2N0M0.
After another assessment by the multidisciplinary tumor
board, we  proposed adjuvant treatment with hormonotherapy
(Tamoxifen®) and adjuvant radiotherapy (RT).
In the ﬁrst evaluation for radiotherapy treatment planning,
she had a good performance status (Karnofsky score of 90%),
with no other complaints except for pain in the left axilla and
a small limitation in the abduction of the left arm.
The 3D Conformal RT (3DCRT) plan consisted of irradiating
the following anatomical regions: left breast, left supraclavi-
cular region and left axilla. A total dose of 50 Gy was prescribed
to the isocenter in 25 fractions of 2 Gy, 5 times a week using
4 MV  photons, plus a boost dose of 10 Gy in 5 fractions of 2 Gy
with bolus.
The treatment occurred in 35 days, without interruptions
and with a good clinical tolerance. After RT, the patient pre-
sented grade II skin erythema in the left breast and moist
desquamation in the left axilla.
One month after RT, she had no skin reaction and was doing
well, without major complaints.
3.  Discussion
Ectopic breast tissue cancer is a rare diagnosis. A palpa-
ble mass followed by edema, tenderness, breast pain is the
most common presentation. Common differential diagnosis
includes lipoma, benign lymphadenopathy, lymphadenitis,
metastatic carcinoma, lymphoma, and hydradenitis suppura-
tiva. In the case of a pigmented axillary lesion, the differential
diagnosis includes seborrheic keratosis, ﬁbromas, and intra-
dermal nevis.1,5,6,11
In most cases, the areola or the nipple is missing and the
initial differential diagnosis does not take into account the EBT
possibility.1,5,6,12 Consequently, a correct preoperative diagno-
sis is rarely made and in case of EBT cancer, the necessary
diagnostic procedures that would have led rapidly to a correct
treatment approach are delayed.1
The clinical evaluation and staging of EBT cancer should
follow the same guidelines as for anatomic breast cancer. In
the case of axillary EBT, an MRI  of the anatomic breast should
be made to exclude a primary breast cancer.1,2,8
Current treatment approach, after exclusion of metastatic
disease, includes local excision with wide margins andiotherapy 1 8 ( 2 0 1 3 ) 189–191
regional lymphadenectomy. In case of axillary EBT carcinoma,
as for the vast majority of all breast cancers, there is no ben-
eﬁt of radical or modiﬁed ipsilateral mastectomy over local
excision.1,4,8,12
The principles of adjuvant treatment are the same as for
anatomic breast cancer and pos-operative radiotherapy to the
tumor site and regional lymph nodes is indicated.3,4,7,8 In cases
of inﬁltration or ulceration of the skin, an additional dose
using bolus is also recommended. Since there is no clear bene-
ﬁt to irradiate homolateral anatomic breast it is not performed
systematically.4 Some authors report that it must be consid-
ered in cases of uncertainty between an axillary EBT or axillary
metastasis from unknown primary breast cancer.2,4
We  decided to irradiate the homolateral breast due to
aggressive histology and tumor location, which would include
part of the anatomic breast in the radiation ﬁeld.
The prognosis is similar compared with carcinoma of the
anatomic breast with the same tumor stage and histology,
although ectopic axillary breast carcinoma has a higher rate
of lymph node involvement,4,6,11 which is a known important
prognostic factor for overall survival.13,14
4.  Conclusion
Carcinoma of an EBT is a rare diagnosis. All EBT around the
breast, especially in the axilla must be considered suspect
until proved otherwise. Due to the atypical location the correct
diagnosis of axillary EBT carcinoma is usually made at a late
stage. Primary local excision with exploration of the axillary
lymph nodes is the main treatment of choice. Adjuvant radia-
tion therapy should include the primary tumor site and to the
lymph nodes following the same guidelines as normal breast
cancer. If any level of uncertainty exists about the diagnosis
of the axillary EBT versus axillary metastasis from unknown
primary breast cancer, irradiation of the homolateral breast
should be included as part of the treatment plan.
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